IMMUNOMODULATORY EFFECT OF GUDUCHI SYRUP IN CHILDREN

STUDY OF MORBIDITY STATUS IN CHILDREN AND THE EFFECT OF GUDUCHI SYRUP AS IMMUNOMODULATOR FOR LOWERING DOWN THE MORBIDITY RATE

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/11/010613

Enrollment

100

Registered

2017-11-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Morbidity status of Children

Interventions

Intervention1: Guduchi Syrup: 1 ml/kg/day of body weight for 3 month from oral route Control Intervention1: Sugar Syrup: 1 ml/kg/day of body weight for 3 month from oral route

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged between 01 to 08 years of either sex. 2. Children with recurrent respiratory infections. 3. Children with recurrent G.I.T. diseases. 4. Children with other recurrent diseases. 5. Children with recurrent fever.

Exclusion criteria

Exclusion criteria: 1. Children with severe diseases. 2. Children with chronic diseases. 3. Children with any genetic disorder. 4. Children having congenital anomalies.

Design outcomes

Primary

Measure	Time frame
Improvement in morbidity features of childrenTimepoint: for 3 months	—

Secondary

Measure	Time frame
Immunomodulatory effect of Guduchi SyrupTimepoint: 3month then follow up of 1 month	—

Countries

India

Contacts

Public ContactDeepak Kumar

National Institute of Ayuved

deepakwhynot@gmail.com9509074322

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026